Neurology® Podcast
Eligibility for Anti-Amyloid Treatment
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:23:27
- More information
Informações:
Synopsis
Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment. Read the related article in Neurology. Visit NPUb.org/Podcast for associated article links.
